Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Aug;77(8):509–514. doi: 10.1136/bjo.77.8.509

Activated T cells in an animal model of allergic conjunctivitis.

I Carreras 1, B Carreras 1, L McGrath 1, A Rice 1, D L Easty 1
PMCID: PMC504586  PMID: 8025049

Abstract

The aim of this study has been to determine whether the presence of lymphocytic infiltrates observed in the histology of ocular allergic conditions in humans or in the late phase of ocular anaphylactic reactions in experimental animals is a non-specific event dependent only on the degranulation of mast cells, or is conditioned by a specific response to antigen. With this in mind, responses to antigen and to a non-immunological mast cell degranulator (compound 48/80) were compared in an experimental model of allergic conjunctivitis. Rats were sensitised to ovalbumin and challenged topically in the left conjunctival sac either with ovalbumin or compound 48/80. The presence of T cells and activated T cells in the infiltrate was studied by immunohistochemical staining on conjunctival tissue obtained at 4, 24, and 48 hours after challenge. Ovalbumin sensitised and challenged rats showed increased numbers of T cells in the conjunctival infiltrate, statistically significant when compared with compound 48/80 challenged rats at 48 hours and with controls at 4, 24, and 48 hours. The number of T cells was significantly higher in compound 48/80 challenged rats only at 48 hours when compared with controls. As for the number of activated T cells, only ovalbumin sensitised and challenged rats showed significantly increased levels of these cells compared with both sensitised animals challenged with compound 48/80 and controls at 4 and 24 hours after challenge. These results suggest that the infiltration of the conjunctiva by activated T lymphocytes is, at least in part, dependent on a specific response to antigen.

Full text

PDF
509

Images in this article

511Image
on p.511
511Image
on p.511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allansmith M. R., Baird R. S., Ross R. N. Morphologic evidence that compound 48/80-challenged rat eyelid mast cells differ in their states of maximal degranulation. Ophthalmic Res. 1989;21(3):206–215. doi: 10.1159/000266809. [DOI] [PubMed] [Google Scholar]
  2. Bhan A. K., Fujikawa L. S., Foster C. S. T-cell subsets and Langerhans cells in normal and diseased conjunctiva. Am J Ophthalmol. 1982 Aug;94(2):205–212. doi: 10.1016/0002-9394(82)90076-9. [DOI] [PubMed] [Google Scholar]
  3. Buckley R. J. Vernal keratoconjunctivitis. Int Ophthalmol Clin. 1988 Winter;28(4):303–308. doi: 10.1097/00004397-198802840-00009. [DOI] [PubMed] [Google Scholar]
  4. Center D. M. Identification of rat mast cell--derived chemoattractant factors for lymphocytes. J Allergy Clin Immunol. 1983 Jan;71(1 Pt 1):29–35. doi: 10.1016/0091-6749(83)90543-2. [DOI] [PubMed] [Google Scholar]
  5. Church M. M., Lai C., Beasley R., Featherstone R. L., Holgate S. T. The mediator and cellular basis of the allergic response. Allergy. 1988;43 (Suppl 8):26–29. doi: 10.1111/j.1398-9995.1988.tb02439.x. [DOI] [PubMed] [Google Scholar]
  6. Dallman M. J., Thomas M. L., Green J. R. MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. Eur J Immunol. 1984 Mar;14(3):260–267. doi: 10.1002/eji.1830140311. [DOI] [PubMed] [Google Scholar]
  7. Doherty M. J., Easty D. L. Inflammatory and immunological cell profiles in a rat model of conjunctival immediate hypersensitivity. Clin Exp Allergy. 1989 Jul;19(4):449–455. doi: 10.1111/j.1365-2222.1989.tb02413.x. [DOI] [PubMed] [Google Scholar]
  8. Donshik P. C. Allergic conjunctivitis. Int Ophthalmol Clin. 1988 Winter;28(4):294–302. doi: 10.1097/00004397-198802840-00007. [DOI] [PubMed] [Google Scholar]
  9. Foster C. S., Rice B. A., Dutt J. E. Immunopathology of atopic keratoconjunctivitis. Ophthalmology. 1991 Aug;98(8):1190–1196. doi: 10.1016/s0161-6420(91)32154-7. [DOI] [PubMed] [Google Scholar]
  10. Gleich G. J. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol. 1982 Sep;70(3):160–169. doi: 10.1016/0091-6749(82)90037-9. [DOI] [PubMed] [Google Scholar]
  11. Johnson R. L., Ziff M. Lymphokine stimulation of collagen accumulation. J Clin Invest. 1976 Jul;58(1):240–252. doi: 10.1172/JCI108455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kay A. B. Eosinophils as effector cells in immunity and hypersensitivity disorders. Clin Exp Immunol. 1985 Oct;62(1):1–12. [PMC free article] [PubMed] [Google Scholar]
  13. Layton G. T., Stanworth D. R. The quantitation of IgG4 antibodies to three common food allergens by ELISA with monoclonal anti-IgG4. J Immunol Methods. 1984 Oct 26;73(2):347–356. doi: 10.1016/0022-1759(84)90410-1. [DOI] [PubMed] [Google Scholar]
  14. Levine B. B., Vaz N. M. Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. A potential mouse model for immune aspects of human atopic allergy. Int Arch Allergy Appl Immunol. 1970;39(2-3):156–171. doi: 10.1159/000230343. [DOI] [PubMed] [Google Scholar]
  15. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med. 1988 Jan 1;167(1):219–224. doi: 10.1084/jem.167.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Maggi E., Del Prete G. F., Tiri A., Macchia D., Parronchi P., Ricci M., Romagnani S. T cell clones providing helper function for IgE synthesis release soluble factor(s) that induce IgE production in human B cells: possible role for interleukin 4 (IL-4). Clin Exp Immunol. 1988 Jul;73(1):57–62. [PMC free article] [PubMed] [Google Scholar]
  17. Malkovský M., Sondel P. M., Strober W., Dalgleish A. G. The interleukins in acquired disease. Clin Exp Immunol. 1988 Nov;74(2):151–161. [PMC free article] [PubMed] [Google Scholar]
  18. Moreau J. F., Bonneville M., Godard A., Gascan H., Gruart V., Moore M. A., Soulillou J. P. Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. J Immunol. 1987 Jun 1;138(11):3844–3849. [PubMed] [Google Scholar]
  19. Paterson D. J., Jefferies W. A., Green J. R., Brandon M. R., Corthesy P., Puklavec M., Williams A. F. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol. 1987 Dec;24(12):1281–1290. doi: 10.1016/0161-5890(87)90122-2. [DOI] [PubMed] [Google Scholar]
  20. Solley G. O., Gleich G. J., Jordon R. E., Schroeter A. L. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest. 1976 Aug;58(2):408–420. doi: 10.1172/JCI108485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tuft S. J., Kemeny D. M., Dart J. K., Buckley R. J. Clinical features of atopic keratoconjunctivitis. Ophthalmology. 1991 Feb;98(2):150–158. doi: 10.1016/s0161-6420(91)32322-4. [DOI] [PubMed] [Google Scholar]
  22. Wahl S. M., Gately C. L. Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin. J Immunol. 1983 Mar;130(3):1226–1230. [PubMed] [Google Scholar]
  23. deShazo R. D., Levinson A. I., Dvorak H. F., Davis R. W. The late phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man. J Immunol. 1979 Feb;122(2):692–698. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES